"Cost-Benefit Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
Descriptor ID |
D003362
|
MeSH Number(s) |
N03.219.151.125
|
Concept/Terms |
Cost-Benefit Analysis- Cost-Benefit Analysis
- Analyses, Cost-Benefit
- Analysis, Cost-Benefit
- Cost-Benefit Analyses
- Cost Benefit Analysis
- Analyses, Cost Benefit
- Analysis, Cost Benefit
- Cost Benefit Analyses
Cost-Utility Analysis- Cost-Utility Analysis
- Analyses, Cost-Utility
- Analysis, Cost-Utility
- Cost Utility Analysis
- Cost-Utility Analyses
Economic Evaluation- Economic Evaluation
- Economic Evaluations
- Evaluation, Economic
- Evaluations, Economic
Marginal Analysis- Marginal Analysis
- Analyses, Marginal
- Analysis, Marginal
- Marginal Analyses
Cost Benefit- Cost Benefit
- Costs and Benefits
- Benefits and Costs
|
Below are MeSH descriptors whose meaning is more general than "Cost-Benefit Analysis".
Below are MeSH descriptors whose meaning is more specific than "Cost-Benefit Analysis".
This graph shows the total number of publications written about "Cost-Benefit Analysis" by people in this website by year, and whether "Cost-Benefit Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 3 | 4 |
1995 | 0 | 3 | 3 |
1996 | 1 | 4 | 5 |
1997 | 3 | 4 | 7 |
1998 | 1 | 8 | 9 |
1999 | 1 | 7 | 8 |
2000 | 0 | 8 | 8 |
2001 | 2 | 8 | 10 |
2002 | 0 | 7 | 7 |
2003 | 0 | 6 | 6 |
2004 | 1 | 3 | 4 |
2005 | 1 | 7 | 8 |
2006 | 0 | 5 | 5 |
2007 | 2 | 11 | 13 |
2008 | 2 | 11 | 13 |
2009 | 1 | 10 | 11 |
2010 | 0 | 11 | 11 |
2011 | 0 | 13 | 13 |
2012 | 1 | 10 | 11 |
2013 | 1 | 10 | 11 |
2014 | 2 | 13 | 15 |
2015 | 3 | 14 | 17 |
2016 | 4 | 17 | 21 |
2017 | 6 | 8 | 14 |
2018 | 3 | 15 | 18 |
2019 | 6 | 15 | 21 |
2020 | 6 | 19 | 25 |
2021 | 5 | 15 | 20 |
2022 | 0 | 13 | 13 |
2023 | 1 | 10 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cost-Benefit Analysis" by people in Profiles.
-
Endovascular Thrombectomy with or without Bridging Thrombolysis in Acute Ischemic Stroke: A Cost-Effectiveness Analysis. Neuroepidemiology. 2024; 58(1):47-56.
-
Cognitive perspectives on maintaining physicians' medical expertise: V. Using a motivational framework to understand the benefits and costs of testing. Cogn Res Princ Implic. 2023 Oct 10; 8(1):64.
-
Health and Economic Impacts of Implementing Produce Prescription Programs for Diabetes in the United States: A Microsimulation Study. J Am Heart Assoc. 2023 08; 12(15):e029215.
-
Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy. Ann Oncol. 2023 08; 34(8):638-644.
-
Accounting for Nonhealth and Future Costs in Cost-Effectiveness Analysis: Distributional Impacts of a US Cancer Prevention Strategy. Pharmacoeconomics. 2023 09; 41(9):1151-1164.
-
Cost-effectiveness Thresholds Used by Study Authors, 1990-2021. JAMA. 2023 04 18; 329(15):1312-1314.
-
What is the cost-effectiveness of menu calorie labelling on reducing obesity-associated cancer burdens? An economic evaluation of a federal policy intervention among 235 million adults in the USA. BMJ Open. 2023 04 18; 13(4):e063614.
-
Developing Criteria for Health Economic Quality Evaluation Tool. Value Health. 2023 08; 26(8):1225-1234.
-
Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation - A cost-effectiveness analysis. Eur J Radiol. 2023 Jun; 163:110803.
-
Is Surgical Repair With Nerve Allograft More Cost-Effective Than Non-Surgical Management for Persistent Trigeminal Neuropathy? Initial Assessment With Markov Model. J Oral Maxillofac Surg. 2023 06; 81(6):674-683.